Lenvatinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Metastatic Clear Cell Renal Cell Carcinoma: A Case Report
Cureus · 28.06.2026
DOI: 10.7759/cureus.111672 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 28.06.2026. Verfasst von Nasong A Luginaah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Schulich School of Medicine and Dentistry, Western University, London, CAN. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Schulich School of Medicine and Dentistry, Western University, London, CAN.
- Department of Oncology, London Health Sciences Centre, London, CAN.
- Department of Clinical Neurological Sciences, London Health Sciences Centre, London, CAN.
- Division of Radiation Oncology, London Health Sciences Centre, Western University, London, CAN.
Zitieren
APA
Luginaah, N. A., Climans, S., & Akingbade, A. (2026). Lenvatinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Metastatic Clear Cell Renal Cell Carcinoma: A Case Report. Cureus. https://doi.org/10.7759/cureus.111672
Vancouver
Luginaah NA, Climans S, Akingbade A. Lenvatinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Metastatic Clear Cell Renal Cell Carcinoma: A Case Report. Cureus. 2026. doi:10.7759/cureus.111672
BibTeX
@article{Luginaah2026,
author = {Luginaah, Nasong A and Climans, Seth and Akingbade, Aquila},
title = {Lenvatinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Metastatic Clear Cell Renal Cell Carcinoma: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.111672}
}
EUVIMED